drugset / Trial / NCT01378754

Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia

NCT01378754

Withdrawn Grace Shih, MD
RandomizedParallel-groupTriple-blindTreatment

Summary

Interstitial cystitis is a condition where a defect in the protective lining of the bladder causes the urinary symptoms such as urgency, frequency and pain/burning on urination. One way to help ease the symptoms of this disease is to fill the bladder full of water every 4 to 6 months. Since this is a painful procedure an anesthesiologist will give you a drug that will make you unconscious for the procedure. General anesthesia can be given to you through an IV tube that is placed in a vein in your arm. There are only a few agents that induce sedation and these agents have certain disadvantages such as waking up slowly, low blood pressure, and pain at the injection site and a prolonged time to consciousness. This study will be comparing doses of a new IV sedation induction agent drug to put you to sleep called fospropofol (Lusedra®).

Timeline

Start
2011-06
Primary completion
2014-05
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject fospropofol Small molecule 6.5 mg/kg Intravenous
Subject fospropofol Small molecule 10 mg/kg Intravenous
Subject fospropofol Small molecule 12 mg/kg Intravenous

Indications